Argenx
ARGX
#638
Rank
A$47.80 B
Marketcap
$799.44
Share price
-0.62%
Change (1 day)
-0.17%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: A$47.80 Billion

As of September 2024 Argenx has a market cap of A$47.80 Billion. This makes Argenx the world's 638th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024A$47.80 B44.32%
2023A$33.12 B7.55%
2022A$30.79 B21.77%
2021A$25.29 B38.99%
2020A$18.19 B85.97%
2019A$9.78 B96.67%
2018A$4.97 B93.73%
2017A$2.56 B
2014A$0.17 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Argenx was reported to be:

A$47.80 Billion
by Yahoo Finance info icon info icon
A$47.80 Billion
by CompaniesMarketCap info icon info icon
A$47.32 Billion
by Nasdaq info icon info icon